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Abstract: Few studies have already been performed to assess oral bacteria during steroid therapy
for oral lichen planus (OLP). Thus, the aim of our study was to analyze the effect of dexamethasone
mouthrinse treatment on the oral bacteria of OLP patients. This prospective study was conducted on
patients who were diagnosed with OLP and treated with 0.05% dexamethasone mouthrinse twice per
day for 4 weeks. Using unstimulated saliva of the patients before and after treatment, the qualitative
and quantitative changes in oral bacteria were analyzed using quantitative real-time polymerase
chain reaction (qPCR). The qPCR results were analyzed using Wilcoxon signed-rank test to the
quantitative changes with dexamethasone mouthrinse. The statistical significance was considered
at a level of 0.05. In total, 20 patients were enrolled in this study, wherein all were noted to show
improved symptoms of OLP. Fifteen patients (75%) had a qualitative change in the oral microbial
species and an improved relative periodontitis risk score (from 26.1 ± 10.7 to 20.9 ± 9.2; p = 0.008).
However, quantitative changes in all species were determined to be not statistically different before
and after the treatment. Most OLP patients had a changed microbial community composition after
0.05% dexamethasone mouthrinse for 4 weeks. In particular, the composition of the periodontopathic
bacteria was improved after the treatment.
Keywords: bacteria; culture technique; dentistry; oral lichen planus; real-time PCR; saliva; periodon-
tology
1. Introduction
Oral lichen planus (OLP) has been identified as a relatively common chronic mucosal
disease that occurs in 0.1–4% of the total population [1]. OLP patients usually often suffer
from poor quality of life with psychological anxiety due to its symptoms, such as difficulty
with pronunciation, swallowing, and tooth brushing [2]. Histological features of OLP in-
clude hyperkeratosis, destruction of basal cells and the basement membrane, T-lymphocyte
infiltration in adjacent connective tissue, and the appearance of Civatte bodies [2]. In terms
of these characteristics, the origin and development process of OLP has not yet been clearly
elucidated. However, it has been revealed that OLP is an autoimmune disease in which an
immunologically mediated attack by T-lymphocytes destroys keratinocytes [3].
Treatment of OLP cannot be focused on a specific target; therefore, it is limited to
symptomatic treatment using immunomodulatory therapy. Steroid therapy has been most
commonly used in symptomatic management, which includes topical application and
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gargling with dexamethasone, fluticasone propionate, and betamethasone sodium phos-
phate [4,5]. Glucocorticoids have potent anti-inflammatory properties showing a decrease
in the number and function of various immune cells, such as T and B lymphocytes, mono-
cytes, neutrophils, and eosinophils, as well as the production of cytokines, chemokines,
and eicosanoids, and enhanced production of macrophage migration inhibitory factors [6].
When used to treat OLP, topical corticosteroids have been known to have fewer
side effects and are comparably as effective as systemic corticosteroids [7]. However,
long-term steroid gargles can affect the oral flora that, in turn, causes bacterial diseases,
such as acute pseudomembranous candidiasis [7]. Therefore, plaque control and rigorous
oral hygiene have been known as a fundamental requisite for the treatment of any oral
disease [8]. Although González-García et al. reported a low risk of fungal over-infection
with triamcinolone acetonide mouthrinse [9], a few studies have reported the change
of oral flora after the use of steroid mouthrinse for treatment of OLP. We hypothesized
that a characteristic bacterial species is activated in the saliva of OLP patients, and the
microbial community composition changes during steroid gargles. Thus, this study aimed
to analyze the qualitative and quantitative changes in oral bacteria using quantitative
real-time polymerase chain reaction (qPCR) in the saliva of OLP patients who were treated
with dexamethasone gargle for 4 weeks.
2. Materials and Methods
2.1. Patients
This prospective study was conducted on patients who were diagnosed with OLP and
treated with 10 mL of 0.05% dexamethasone gargle twice per day. OLP was diagnosed in
patients with hypersensitivity to hot or spicy food, and reticular-patterned, atrophic, and
white lesions in the oral cavity by an expert clinician with ≥23 experience. This study was
reviewed and approved by the Institutional Review Board at Seoul National University
Bundang Hospital (No. B-1704-393-305). All patients were informed about the conducting
of this study and agreed in writing to participate.
The inclusion criteria were as follows: (1) age over 18 years; (2) informed consent
from voluntary participants; (3) self-managing oral hygiene with a pocket depth of teeth
within 1–3 mm without calculus or gingivitis; and (4) dexamethasone gargle use for only
4 weeks. On the other hand, the exclusion criteria were as follows: (1) lack of agreement to
participate in the study; (2) a history of steroid treatment within 3 months before the start of
the study; (3) a history of systemic or local antibiotics within 3 months before the start of the
study; (4) untreated periodontitis or dental caries; (5) current smoker; and (6) uncontrolled
systemic diseases or the presence of a dentofacial-related deformity or syndrome.
2.2. Saliva Analysis
Unstimulated saliva was collected from the 28 patients before treatment with dexam-
ethasone gargle, and after 4 weeks of treatment, unstimulated saliva was collected again
for analysis. The saliva samples were collected via 10 mL of EasyGen mouth rinse (YD
Global Lifescience, Seongnam-si, Gyeonggi-do, Korea). All participants gargled for 20 s
using mouthwash, and the samples were collected into a specimen bucket. DNA extraction
was conducted using a QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) [10]. The
DNA extraction was performed according to the manufacturer’s instructions.
2.3. Multiplex Quantitative Real-Time Polymerase Chain Reaction (qPCR)
qPCR was performed according to the manufacturer’s instructions using an EasyPerio
(YD Global Lifescience, Seongnam-si, Gyeonggi-do, Korea) that consisted of Oligo Mix, 2×
Master mix. The PCR mixture was prepared using 9 µL of Oligo Mix, 10 µL of 2× Master
Mix, and 1 µL of template DNA. The CFX96 Touch™ Real-Time PCR Detection System
(Bio-Rad, Hercules, CA, USA) was used for qPCR. The PCR conditions were as follows:
pre-denaturation for 30 s at 95 ◦C, followed by 40 cycles of 5 s denaturation at 95 ◦C, and
30 s extension and annealing at 62 ◦C. Scanning of fluorescence was performed after the
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extension and annealing processes. According to the bacterial species, the results of qPCR
were calculated with a relative fluorescence unit (RFU) and classified into Porphyromonas
gingivalis (Pg), Tannerella forsythia (Tf), Treponema denticola (Td), Fusobacterium nucleatum
(Fn), Prevotella intermedia (Pi), Prevotella nigrescens (Pn), Streptococcus mitis (Sm), Streptococcus
mutans (Smu), and Streptococcus sobrinus (Ss).
Considering the ecological proportion of bacterial populations according to periodon-
tal health [11], the EasyPerio automatically calculated the relative periodontitis risk score
(PR-score) and caries risk score (CR-score) [12]. The data were analyzed with sequenced-
detection system software (ABI 7500 Fast Real-Time PCR System, version 1.4.1., Applied
Biosystems, Life Technologies Inc., Forest City, IA, USA). The threshold cycle values were
measured using standard curves for the number of bacterial cells from known amounts of
bacterial-specific DNA.
2.4. Statistical Analysis
The qPCR results were compared to the quantitative changes before and after dexam-
ethasone treatment using Wilcoxon signed-rank test. In addition, absolute quantitative
changes were compared to analyze the effect of dexamethasone on oral microflora. Data
are presented as mean ± standard deviation, and statistical analysis was performed using
SPSS 25.0 for Windows (SPSS Inc., Chicago, IL, USA). Significance was considered at a
level of 0.05.
3. Results
We enrolled 28 patients in this study, of whom eight were excluded because of in-
sufficient saliva secretion or poor quality of the saliva sample (1 male, 19 females; age
61.1 ± 11.8 years) (Figure 1).
Figure 1. Flow diagram of the exclusion and research steps.
All patients showed improved symptoms of OLP after four weeks of dexamethasone
gargling, whereas 15 of the 20 patients (75%) showed qualitative changes in oral microbial
species after 4 weeks of dexamethasone gargle (Table 1). After steroid therapy, the detection
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frequency was decreased for four microbial species: Tf (65% to 50%), Td (15% to 10%), Pi
(30% to 15%), and Pn (75% to 55%). Furthermore, the detection frequency was maintained
for the other four species: Pg (55%), Fn (100%), Sm (100%), and Smu (40%; Table 1).
Table 1. Demographic information and qualitative changes in the oral bacterial species of the oral lichen planus patients
before and after the treatment with dexamethasone gargle.
Patient Number Age Sex
Qualitative Results of Oral Bacterial Species
Pg Tf Td Fn Pi Pn Sm Smu Ss Change
#1 58 F N P N P N - P P - •
#2 67 F - P N P N P P P N •
#3 81 F N N N P N N P N N
#4 70 F P P + P N - P N N •
#5 72 F P P N P N P P N N
#6 67 F P N N P - P P P N •
#7 68 F P P N P N P P + N •
#8 54 F P P P P - P P N N •
#9 73 F P N N P N N P P N
#10 59 F + + N P - N P N N •
#11 39 F N P N P N P P P N
#12 60 F P P - P P - P P - •
#13 56 F N P N P N P P N N
#14 56 F N - N P N P P N N •
#15 59 F + - - P N - P N N •
#16 72 F P N N P P + P N N •
#17 73 M P N N P N N P P N
#18 53 F N N N P P - P N N •
#19 33 F - - N P N P P N N •
#20 52 F N - N P N P P - N •
Pg, Porphyromonas gingivalis; Tf, Tannerella forsythia; Td, Treponema denticola; Fn, Fusobacterium nucleatum; Pi, Prevotella intermedia;
Pn, Prevotella nigrescens; Sm, Streptococcus mitis; Smu, Streptococcus mutans; Ss, Streptococcus sobrinus, P: positive, N: negative,
+: change from negative to positive, -: change from positive to negative. •: Change in more than one species.
The PR scores significantly reduced by 5.2 ± 7.5 after the treatment (from 26.1 ± 10.7
to 20.9 ± 9.2, p = 0.008). The CR scores decreased by 1.8 ± 6.8 after the treatment (from
23.1 ± 9.5 to 21.3 ± 5.8) without significance (p = 0.492; Figure 2).
Figure 2. The relative periodontitis and caries risk scores after 4 weeks of dexamethasone treatment.
(**: Wilcoxon signed-rank test significance level at 0.01; CR-score, relative caries risk score; PR-score,
relative periodontitis risk score).
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The absolute quantitative changes of oral microbial species were significant except
for Td and Ss (0.7 ± 1.5, 104 RFU and 0.5 ± 1.9, 105 RFU, respectively; Table 2). The
average quantitative changes in oral microbial species were reduced except for Td and Pn
(0.1 ± 1.7 and 0.0 ± 1.7, 104 RFU, respectively). However, the quantitative changes were not
statistically significantly different before and after the treatment (Figure 3, Supplementary
Table S1).
Table 2. Absolute quantitative changes in the oral microbial species of oral lichen planus patients before and after treatment
with dexamethasone gargle.
Patient Number



















Total 1.5 (2.1) 1.5 (1.8) 0.7 (1.5) 1.2 (1.7) 1.1 (2.2) 1.1 (1.2) 2.5 (2.8) 1.2 (1.5) 0.5 (1.9)
p-value * 0.001 0.002 0.068 0.000 0.018 0.001 0.000 0.008 0.180
Pg, Porphyromonas gingivalis; Tf, Tannerella forsythia; Td, Treponema denticola; Fn, Fusobacterium nucleatum; Pi, Prevotella intermedia;
Pn, Prevotella nigrescens; Sm, Streptococcus mitis; Smu, Streptococcus mutans; Ss, Streptococcus sobrinus. *: Wilcoxon signed-rank test.
Figure 3. Quantitative changes in oral microbial species in OLP patients after 4 weeks of dexamethasone gargle. (Pg:
Porphyromonas gingivalis, 105 RFU; Tf: Tannerella forsythia, 105 RFU; Td: Treponema denticola, 104 RFU; Fn: Fusobacterium
nucleatum, 106 RFU; Pi: Prevotella intermedia, 106 RFU; Pn: Prevotella nigrescens, 104 RFU; Sm: Streptococcus mitis, 106 RFU;
Smu: Streptococcus mutans, 105 RFU; Ss: Streptococcus sobrinus, 105 RFU).
4. Discussion
In this study, we analyzed the qualitative and quantitative changes in oral bacteria of
OLP patients. After 4 weeks of corticosteroid gargle use, 75% of the OLP patients had a
changed microbial community composition. The amount of change was significant except
for Treponema denticola and Streptococcus sobrinus. Overall, the total number of microbes
appeared to decrease, but there was no consistent result for all patients or bacterial species.
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In the human oral cavity, about 700 bacterial species of phylogenies are identified
as essential for maintaining a healthy condition, but some oral pathogens may exert the
ability to differently trigger the activation of local immune responses with an imbalance
of pro-inflammatory and anti-inflammatory gene responses [13–15]. The effect of the oral
microbial population has not yet been clarified in the development of OLP, which is consid-
ered an oral immune disease. Lundstrom et al. first reported in 1984 that 37–50% of OLP
patients had candidiasis [16]. Until 2000, Helicobacter pylori was the only bacterium believed
to be attributed to OLP [17,18]. In 2008, Bornstein et al. showed high bacterial counts
of Bacteroides ureolyticus, Dialister species, Staphylococcus haemolyticus, and Streptococcus
agalactiae in OLP lesions by using a closed-format checkerboard DNA-DNA hybridization
method [19]. In this present study, Fn and Sm were detected in all OLP patients, and the
other species were observed in the following order: Pn (75%), Tf (65%), Pg (55%), Smu
(40%), Pi (30%), Td (15%), and Ss (10%). However, the relationship could not be elucidated
between OLP development and microbial species because no comparison was made with
healthy patients without OLP.
Although OLP is associated with T-lymphocytes without bacterial infection, it can be
affected by oral pathogens that secrete endotoxins and stimulate the immune system [2]. In
1990, Holmstrup et al. found that intensive oral hygiene management improved symptoms
in patients with atrophic and ulcerative OLP [20]. In 2007, chlorhexidine treatment was
shown to significantly relieve the symptoms of OLP [21]. These reports suggested that the
oral microbial community may interact with the symptoms or development of OLP.
On the other hand, immunomodulatory activity can affect the oral microbial com-
munity while suppressing the immunologic system during OLP treatment. In 2020, a
systematic review revealed that systemic steroid was associated with the incidence of
periodontal disease [22]. Even though steroid gargle has fewer side effects than systemic
steroids, the possibility has been suggested that there could be a change in the composition
of the microbial community during steroid mouthrinse therapy [7]. However, there has
been a lack of study for indigenous bacterial populations with steroid gargles. As per
our findings, 75% of patients had an altered oral microbial composition during 4 weeks
of dexamethasone mouthrinse. These results suggest that the distribution of commensal
bacteria could be affected by the steroid gargle and might be associated with the possibility
of an individual to dental caries and periodontal disease.
Oral bacteria can be classified into periodontopathic and cariogenic bacteria. Among
them, EasyPerio (YD Global Lifescience, Seongnam-si, Gyeonggi-do, Republic of Korea)
can detect six periodontopathic (Pg, Tf, Td, Fn, Pi, and Pn) and two cariogenic (Sm and
Smu) species. In particular, the dexamethasone mouthrinse significantly affected periodon-
topathic bacteria, but not cariogenic bacteria, as shown in Figure 1. Qualitatively, the four
species reduced the frequency of detection, that is, Tf, Pi, Pn, Td, and Ss, and the others
remained the same, i.e., Pg, Fn, Sm, and Smu. Quantitatively, the absolute amount of the
bacteria was significantly changed, or the six species (Pg, Tf, Fn, Pi, Pn, Sm, and Smu) were
changed, except for Td and Ss. However, the tendency of the increase or decrease in the
number of bacteria was different for each patient; thus, the total number of bacteria showed
no statistical difference among all patients.
Based on a recent advent of high-throughput sequencing technology, many researchers
have tried to demonstrate the profiles of the bacterial community associated with OLP to
determine the role of bacterial infection in the cause and progression of OLP [23,24]. To
date, no dysbiosis has yet proven the causality of OLP [25]. On the other hand, there has
not been much attention to the bacterial community or dysbiosis of OLP patients during
their steroid treatment. With regard to the present results, the numbers and species of the
oral microbial were greatly affected by dexamethasone treatment for 4 weeks. The effect
was positive for reducing the relative periodontitis risk. Therefore, the OLP patients who
received steroid therapy developed new healthy normal microflora through intensive oral
hygiene management or probiotics to ameliorate microbial dysbiosis [26].
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This study has some limitations in that the results did not demonstrate whether the
improvement in OLP symptoms was due to the effect of dexamethasone gargle since
there was the absence of a negative control showing no improvement in OLP or a positive
control without the history of OLP. Due to the nature of the pilot study, we could not
include sufficient patients with various populations, various concentrations, and types
of mouthrinse. Furthermore, some unexplored variables can have a significant influence
on the oral environment. For example, the use of probiotics and natural compounds can
modify the clinical and microbiological parameters [27,28]. Therefore, they could also have
an effect in patients affected with lichen planus. These variables should be considered in
future clinical trials.
5. Conclusions
In this present study, most patients had a changed microbial community composition
even though quantitative changes in oral microbial species were not found. Our results
indicated that the composition of some periodontopathic bacteria changed positively after
4 weeks of gargling with 10 mL of 0.05% dexamethasone. Therefore, clinicians should
consider that dexamethasone was affected oral bacteria. Further clinical study should be
conducted with periodontitis patients.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/app11146286/s1, Table S1: Quantitative changes in oral microbial species of oral lichen
planus patients.
Author Contributions: This research was made possible by the personal contributions of the follow-
ing persons: J.-K.K. for writing original draft preparation, S.-Y.P. and P.-Y.Y. for conceptualization
and methodology. J.-K.K. and P.-Y.Y. performed the data curation and the statistical analysis, K.-G.H.
performed software support and financial support. All authors have read and agreed to the published
version of the manuscript.
Funding: This research was supported by a grant of the Korea Health Technology R & D Project
through the Korea Health Industry Development Institute, funded by the Ministry of Health and
Welfare, Republic of Korea (grant number: HI20C0013).
Institutional Review Board Statement: This study was reviewed and approved by the Institutional
Review Board at Seoul National University Bundang Hospital (No. B-1704-393-305).
Informed Consent Statement: Written informed consent was obtained from all participants) to
publish this paper.
Data Availability Statement: The data presented in this study are available on request from the
corresponding author.
Conflicts of Interest: All the authors of this work wish to disclose that there are no financial or other
conflicts of interest that might have biased the scientific information in this article.
References
1. Lodi, G.; Scully, C.; Carrozzo, M.; Griffiths, M.; Sugerman, P.B.; Thongprasom, K. Current controversies in oral lichen planus:
Report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg. Oral Med. Oral Pathol. Oral
Radiol. Endodontol. 2005, 100, 40–51. [CrossRef]
2. Sugerman, P.B.; Savage, N.W. Oral lichen planus: Causes, diagnosis and management. Aust. Dent. J. 2002, 47, 290–297. [CrossRef]
3. Masaki, M.; Sato, T.; Sugawara, Y.; Sasano, T.; Takahashi, N. Detection and identification of non-Candida albicans species in
human oral lichen planus. Microbiol. Immunol. 2011, 55, 66–70. [CrossRef]
4. Levin, C.; Maibach, H.I. Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications. Am. J. Clin. Dermatol.
2002, 3, 141–147. [CrossRef]
5. Hegarty, A.M.; Hodgson, T.A.; Lewsey, J.D.; Porter, S.R. Fluticasone propionate spray and betamethasone sodium phosphate
mouthrinse: A randomized crossover study for the treatment of symptomatic oral lichen planus. J. Am. Acad. Dermatol. 2002, 47,
271–279. [CrossRef] [PubMed]
6. Gibson, N.; Ferguson, J.W. Steroid cover for dental patients on long-term steroid medication: Proposed clinical guidelines based
upon a critical review of the literature. Br. Dent. J. 2004, 197, 681–685. [CrossRef]
Appl. Sci. 2021, 11, 6286 8 of 8
7. Lodi, G.; Manfredi, M.; Mercadante, V.; Murphy, R.; Carrozzo, M. Interventions for treating oral lichen planus: Corticosteroid
therapies. Cochrane Database Syst. Rev. 2020, 2, CD001168. [CrossRef] [PubMed]
8. Scattarella, A.; Petruzzi, M.; Ballini, A.; Grassi, F.R.; Nardi, G.M. Oral lichen planus and dental hygiene: A case report.
Int. J. Dent. Hyg. 2010, 9, 163–166. [CrossRef] [PubMed]
9. González-García, A.; Diniz-Freitas, M.; Vila, P.G.; Blanco-Carrión, A.; Garcia-Garcia, A.; Gándara-Rey, J. Triamcinolone acetonide
mouth rinses for treatment of erosive oral lichen planus: Efficacy and risk of fungal over-infection. Oral Dis. 2006, 12, 559–565.
[CrossRef]
10. Mirsepasi, H.C.; Persson, S.; Struve, C.; Andersen, L.O.B.; Petersen, A.M.; Krogfelt, K.A. Microbial diversity in fecal samples de-
pends on DNA extraction method: easyMag DNA extraction compared to QIAamp DNA stool mini kit extraction. BMC Res. Notes
2014, 7, 50. [CrossRef]
11. Takeshita, T.; Nakano, Y.; Kumagai, T.; Yasui, M.; Kamio, N.; Shibata, Y.; Shiota, S.; Yamashita, Y. The ecological proportion of
indigenous bacterial populations in saliva is correlated with oral health status. ISME J. 2008, 3, 65–78. [CrossRef]
12. Kim, S.-J.; Rim, D.; Heo, J.U.; Cho, H.-J. Possibility of predicting missing teeth using deep learning: A pilot study. J. Korean Acad.
Oral Health 2019, 43, 210–216. [CrossRef]
13. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the Normal Bacterial Flora of the Oral Cavity. J. Clin. Microbiol.
2005, 43, 5721–5732. [CrossRef]
14. Ballini, A.; DiPalma, G.; Isacco, C.G.; Boccellino, M.; Di Di Domenico, M.; Santacroce, L.; Nguyễn, K.C.; Scacco, S.; Calvani,
M.; Boddi, A.; et al. Oral Microbiota and Immune System Crosstalk: A Translational Research. Biology 2020, 9, 131. [CrossRef]
[PubMed]
15. Inchingolo, F.; Martelli, F.S.; Isacco, C.G.; Borsani, E.; Cantore, S.; Corcioli, F.; Boddi, A.; Nguyễn, K.C.; De Vito, D.; Aityan, S.K.;
et al. Chronic Periodontitis and Immunity, Towards the Implementation of a Personalized Medicine: A Translational Research on
Gene Single Nucleotide Polymorphisms (SNPs) Linked to Chronic Oral Dysbiosis in 96 Caucasian Patients. Biomedicines 2020,
8, 115. [CrossRef] [PubMed]
16. Lundström, I.M.; Anneroth, G.B.; Holmberg, K. Candida in patients with oral lichen planus. Int. J. Oral Surg. 1984, 13, 226–238.
[CrossRef]
17. Riggio, M.P.; Lennon, A.; Wray, D. Detection of Helicobacter pylori DNA in recurrent aphthous stomatitis tissue by PCR.
J. Oral Pathol. Med. 2000, 29, 507–513. [CrossRef] [PubMed]
18. Shimoyama, T.; Horie, N.; Kato, T.; Kaneko, T.; Komiyama, K. Helicobacter pylori in oral ulcerations. J. Oral Sci. 2000, 42, 225–229.
[CrossRef]
19. Bornstein, M.M.; Hakimi, B.; Persson, G.R. Microbiological Findings in Subjects With Asymptomatic Oral Lichen Planus: A
Cross-Sectional Comparative Study. J. Periodontol. 2008, 79, 2347–2355. [CrossRef]
20. Holmstrup, P.; Schiøtz, A.W.; Westergaard, J. Effect of dental plaque control on gingival lichen planus. Oral Surg. Oral Med.
Oral Pathol. 1990, 69, 585–590. [CrossRef]
21. Backman, K.; Jontell, M. Microbial-associated oral lichenoid reactions. Oral Dis. 2007, 13, 402–406. [CrossRef] [PubMed]
22. Brasil-Oliveira, R.; Cruz, Á.A.; Sarmento, V.A.; Souza-Machado, A.; Lins-Kusterer, L. Corticosteroid Use and Periodontal Disease:
A Systematic Review. Eur. J. Dent. 2020, 14, 496–501.
23. Wang, K.; Lu, W.; Tu, Q.; Ge, Y.; He, J.; Zhou, Y.; Gou, Y.; Van Nostrand, J.; Qin, Y.; Li, J.; et al. Preliminary analysis of salivary
microbiome and their potential roles in oral lichen planus. Sci. Rep. 2016, 6, 22943. [CrossRef] [PubMed]
24. Choi, Y.S.; Kim, Y.; Yoon, H.-J.; Baek, K.J.; Alam, J.; Park, H.K.; Choi, Y. The presence of bacteria within tissue provides insights
into the pathogenesis of oral lichen planus. Sci. Rep. 2016, 6, 29186. [CrossRef]
25. Baek, K.; Choi, Y. The microbiology of oral lichen planus: Is microbial infection the cause of oral lichen planus? Mol. Oral Microbiol.
2017, 33, 22–28. [CrossRef]
26. Allaker, R.P.; Stephen, A.S. Use of Probiotics and Oral Health. Curr. Oral Health Rep. 2017, 4, 309–318. [CrossRef]
27. Butera, A.; Gallo, S.; Maiorani, C.; Molino, D.; Chiesa, A.; Preda, C.; Esposito, F.; Scribante, A. Probiotic Alternative to
Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters. Microorganisms 2020, 9, 69.
[CrossRef]
28. Costa-Pinto, A.; Lemos, A.; Tavaria, F.; Pintado, M. Chitosan and Hydroxyapatite Based Biomaterials to Circumvent Periprosthetic
Joint Infections. Materials 2021, 14, 804. [CrossRef]
